The inception of Advanced Brain is a strategic expansion of Wiley’s renowned Advanced Portfolio, which is dedicated to high-impact journals that promote cross-disciplinary collaborations and streamline scientific publishing. The portfolio’s expansion aligns with Wiley’s broader vision of accelerating transformative science by facilitating easier submission processes and reducing redundant resubmissions, thereby enabling scientists to disseminate knowledge more efficiently. Researchers now have the advantage of publishing their work with increased flexibility and editorial support, ensuring that investigations reach their optimal audience and foster impactful interdisciplinary connections.

To underscore the journal’s goal of integrating multiple research perspectives, Advanced Brain is designed to cover the full continuum of the brain and mind, encompassing molecular and cellular neurobiology, systems neuroscience, cognitive processes, neuroimaging techniques, computational modeling, alongside translational and clinical research. Such a holistic approach reflects the recognition that neural complexity demands multifaceted investigative frameworks. This editorial scope offers opportunities for studies on neurodegeneration, brain injury, sensory disorders, mental health, neuroinflammation, and more, positioning the journal at the forefront of brain science innovation.

The leadership of Advanced Brain is entrusted to Editor-in-Chief Antonia Eisenkoeck, whose extensive background in prestigious publishing roles—formerly with The Lancet Neurology and Nature Portfolio—provides a robust editorial foundation. Her expertise in psychology, backed by a PhD from Goldsmiths, University of London, equips her with insights into both fundamental and clinical neuroscience disciplines. Eisenkoeck emphasizes the journal’s mission to dismantle disciplinary silos that have traditionally isolated neuroscience, neurology, psychiatry, and psychology, thereby accelerating discovery pipelines that span from basic mechanisms to population-level studies and clinical frameworks.

From an editorial philosophy perspective, Advanced Brain mirrors the Advanced Portfolio’s hallmark of close collaboration between professional editors and contributing scientists. This synergy is critical in identifying the most suitable publication venues within the portfolio’s interconnected journals, thereby minimizing the inefficiencies that commonly burden academic publishing. This innovative editorial model not only enhances author experience but also maximizes research visibility and impact, encouraging reproducibility and rigorous peer evaluation.

Moreover, Advanced Brain boasts an impressive international advisory board comprising leading academics representing a global spectrum of brain sciences. Esteemed institutions such as the University of Oxford, Harvard University, Fudan University, the University of Hong Kong, and the University of Oslo contribute to shaping the journal’s intellectual rigor and scholarly direction. This diverse scholarly input ensures the publication remains at the cutting edge of global research trends and scientific discourse.

The journal’s launch is timely given the accelerating need for integrative brain research that transcends traditional boundaries. Neuroscience and allied disciplines are increasingly focusing on complex challenges such as neurodegenerative conditions, stroke rehabilitation, psychiatric disorders, and the neural bases of cognition and behaviour. Advanced Brain aims to catalyze research that not only elucidates underlying biological processes but also translates into clinical practices and public health policies, ultimately enhancing patient outcomes and societal well-being.

In addition, the journal’s inclusion in Wiley’s Advanced Portfolio emphasizes the evolving landscape of scholarly publishing, where interdisciplinarity is paramount. Previously focused on materials science, the portfolio has expanded to include journals addressing the confluence of artificial intelligence and scientific innovation, like Advanced Intelligent Discovery and Advanced Robotics Research. This strategy reflects Wiley’s commitment to adapting to emerging scientific frontiers and supporting the dynamic needs of the research community.

The open access model adopted by Advanced Brain ensures unfettered dissemination of knowledge to researchers, healthcare professionals, policymakers, and the public. This model promotes transparency, accelerates scientific progress, and fosters equitable access to information, a crucial factor for global collaborative efforts in brain research. It also facilitates rapid integration of discoveries into practical solutions and therapeutic strategies.

In summation, Advanced Brain represents a visionary platform for transformative integrative neuroscience research, uniting distinct yet related disciplines under one umbrella. By promoting an inclusive and dynamic approach to brain science inquiries, it aspires to be instrumental in shaping future research paradigms, improving clinical interventions, and influencing health policies. Wiley’s dedication to innovation and excellence shines through the launch of this journal, marking a new chapter in scholarly communication and scientific advancement centered around the most intricate organ—the human brain.

Subject of Research: Neuroscience, Neurology, Psychiatry, and Psychology

News Publication Date: Not explicitly stated in the original content

Web References:

• The Advanced Portfolio – Wiley Online Library: https://advanced.onlinelibrary.wiley.com/
• Wiley Official Site: https://www.wiley.com/en-us
• Wiley Investor Relations: https://investors.wiley.com/overview/default.aspx

Image Credits: Wiley

Keywords: Neuroscience, Neurology, Psychiatry, Psychology, Brain Research, Open Access, Interdisciplinary Science, Neurodegenerative Diseases, Neuroinflammation, Psychiatric Disorders, Translational Neuroscience, Cognitive Science

At the forefront of this movement is the Synapsy Center for Neuroscience and Mental Health Research at the University of Geneva. This center aims to bridge the longstanding divide between fundamental neuroscientific research and practical psychiatric applications. The impending launch of the Synapsy Prize in spring 2025, which will offer a notable award of 50,000 CHF for exceptional contributions at the intersection of neuroscience and psychiatry, exemplifies their commitment to fostering collaboration in this critical field.

The Synapsy Prize seeks to honor individuals who have demonstrated a significant impact on both research and clinical advancement. Professor Christian Lüscher, who coordinates the Synapsy Center and leads the prize committee, underscores the importance of integrating laboratory findings with clinical practices. He emphasizes that only by creating closer ties between these two domains can the future of mental health research be secured. The prize is not merely an award but a beacon of hope designed to motivate researchers to innovate, inspire, and strive for excellence in understanding psychiatric illnesses.

Psychiatric disorders represent a considerable public health burden, affecting hundreds of millions of people around the world. The challenges faced by the psychiatric field are compounded by stringent limitations in clinical advances, with many diagnoses lacking definitive biomarkers and treatment plans often being overly general and imprecise. As such, an urgent re-evaluation of existing research models is necessary to enhance patient care and therapeutic strategies.

Despite significant strides in understanding the brain and its functions, translation of neuroscientific discoveries into effective treatment strategies remains elusive. This stark disconnect is partially attributable to the traditional separation between the realms of neuroscience and psychiatry, a gap that the Synapsy Center seeks to close. By uniting researchers from both disciplines, the center aims to enhance translational research efforts, ultimately facilitating a more integrated approach to mental health treatment.

To kickstart this initiative, the Synapsy Center draws upon its heritage from the Swiss National Science Foundation’s Synapsy National Center of Competence in Research, which operated from 2010 to 2022. This legacy has equipped the Synapsy Center with a robust foundation of expertise and collaboration, essential for the mission of advancing mental health research. Bringing together leading figures in neuroscience and clinical psychiatry is crucial in paving the way for innovative therapeutic techniques and diagnostic tools.

Nominations for the Synapsy Prize will be open from early April to June 30, 2025, creating an opportunity for the global scientific community to acknowledge and celebrate outstanding contributions to the field. Peer nominations are encouraged, ensuring that the selection process highlights the most impactful advancements. The prize jury will comprise esteemed Swiss experts from various academic institutions, including UNIGE, the University of Lausanne, and EPFL, accompanied by a member representing a patient association. This diverse jury is designed to reflect the interdisciplinary nature of contemporary mental health research and the various stakeholders involved.

The winner of the Synapsy Prize will have the distinct honor of delivering a public conference and leading a Master Class for young researchers at the Campus Biotech in Geneva in December 2025. This event aims to disseminate knowledge and share insights gained from the recipient’s work while inspiring the next generation of researchers to pursue excellence in bridging the divide between neuroscience and psychiatry.

As additional details about the prize emerge, the Synapsy Center encourages researchers and mental health advocates to look for updates on their official website. The prize symbolizes a turning point in the realm of mental health, representing a concerted effort to foster collaboration, innovation, and progress in understanding and treating psychiatric disorders.

In conclusion, The Synapsy Prize serves as a critical acknowledgment of the necessity for synergy between neuroscientific research and psychiatric practice. Mental health is a critical issue that demands immediate attention, and through initiatives such as this prize, there is hope for a future where innovative research translates seamlessly into actionable clinical practice. As the fields of neuroscience and psychiatry continue to grow and evolve, it is imperative that researchers are recognized and rewarded for their work in this essential area of study, potentially transforming the lives of millions suffering from mental health disorders worldwide.

Subject of Research: Neuroscience and Psychiatry
Article Title: Synapsy Center Launches Prize to Bridge Neuroscience and Psychiatry
News Publication Date: TBD
Web References: www.synapsy-prize.ch
References: TBD
Image Credits: © Synapsy

Keywords: Mental Health, Neuroscience, Psychiatry, Synapsy Prize, Research Collaboration, Psychiatric Disorders, Translational Research, Clinical Practice.